Dr. Paul Marik | Remdesivir - December 18, 2021
529 Views
22
Dr. Paul Marik on Remdesivir at the 12/18 Nashville COVID Summit:
“Halfway through the study they did an interim analysis and found that the study was not going to be positive. So they changed the end point, the goal post, halfway through the study. That is called scientific misconduct.”
This Content Is Mirrored. Please support the original creator. All credit, royalties and sincere thanks to the original source of this video
NTD Video Dec 18, 2021. https://www.ntd.com/upcoming-global-covid-summit-nashville_715751.html
IMG_6866
Dr. Paul Marik | Remdesivir - December 18, 2021
Dr. Paul Marik, Remdesivir, the Nashville COVID Summit, December 18, 2021
“Halfway through the study they did an interim analysis and found that the study was not going to be positive. So they changed the end point, the goal post, halfway through the study. That is called scientific misconduct.”
This Content Is Mirrored. Please support the original creator. All credit, royalties and sincere thanks to the original source of this video
NTD Video Dec 18, 2021. https://www.ntd.com/upcoming-global-covid-summit-nashville_715751.html
IMG_6866
Dr. Paul Marik | Remdesivir - December 18, 2021
Dr. Paul Marik, Remdesivir, the Nashville COVID Summit, December 18, 2021